Provided by Tiger Trade Technology Pte. Ltd.

NeOnc Technologies Holdings

3.01
-0.3000-9.06%
Volume:109.58K
Turnover:342.70K
Market Cap:86.70M
PE:-1.41
High:3.41
Open:3.41
Low:3.00
Close:3.31
52wk High:12.99
52wk Low:3.00
Shares:28.81M
Float Shares:15.86M
Volume Ratio:1.45
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1361
EPS(LYR):-3.2036
ROE:--
ROA:-634.99%
PB:-4.00
PE(LYR):-0.94

Loading ...

NASDAQ Trade Halt Halt News Pending at 07:55 Am

Reuters
·
Aug 12

NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears

GlobeNewswire
·
Aug 10

NeOnc Technologies Q2 EPS $(0.58) Misses $(0.15) Estimate

Benzinga Earnings
·
Aug 10

Neonc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a Neo100 Data Readout

THOMSON REUTERS
·
Aug 10

Neonc Technologies - Q2 2026 Net Loss $14.20 Mln or $(0.58) Per Diluted Share

THOMSON REUTERS
·
Aug 10

Press Release: NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a Neo100 Data Readout

Dow Jones
·
Aug 10

NeOnc Technologies Hosts Call on Phase 2a Topline Data for Intranasal Neo100 in Recurrent IDH1-Mutant Glioma

Reuters
·
Aug 10

NeOnc Technologies Appoints Accenture Strategy Executive Nasim Shomali to Board

Reuters
·
Jul 27

Neonc Technologies Appoints Strategy and Finance Executive Nasim Shomali to Its Board of Directors

THOMSON REUTERS
·
Jul 27

Press Release: NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to Its Board of Directors

Dow Jones
·
Jul 27

Neonc Gets FDA Written Feedback Backing Neo212 CMC Plan, Flags Bioavailability Study for Tablet Switch

Reuters
·
Jul 15

Neonc Technologies - FDA Finds Neonc's Cmc Development Approach Reasonable with Conditions on Manufacturing Changes

THOMSON REUTERS
·
Jul 15

Neonc Receives FDA Written Feedback on Neo212 Cmc Development and Capsule-to-tablet Transition

THOMSON REUTERS
·
Jul 15

Neonc Technologies - Cancels July 9 FDA Meeting After Sufficient Written Responses

THOMSON REUTERS
·
Jul 15

Neonc Technologies - to Update Neo212 Development Plan After Incorporating FDA Feedback

THOMSON REUTERS
·
Jul 15

Bullish NeOnc Technologies Holdings Insider Buying Worth US$615.6k Yet To Pay Off

Simply Wall St.
·
Jul 15

Neonc Technologies Director Nasim Shomali Files Initial Beneficial Ownership Statement

Reuters
·
Jul 14

Neonc Technologies Names Nasim Shomali to Board After Chiang Resignation

Reuters
·
Jul 03

Neonc Wins UAE IND Authorization for Neo100 in Recurrent High-grade Glioma

Reuters
·
Jun 24

NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum

GlobeNewswire
·
Jun 24